Zorilla Research LLC has a simple goal: Transform how companies develop new drugs for animal and human health through the application of computational screening. Research and development for new drugs is becoming ever more difficult and expensive due to the high cost of late stage drug failures and the low productivity of early stage screening where researchers test thousands and sometimes millions of possible molecule combinations. Zorilla Research offers companies a way to mitigate the high cost of failure and a solution to the industry’s core problem of declining R&D productivity.